Genetic Testing: Market Research Report

Date: January 5, 2017
Pages: 408
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G6B8B51407CEN
Leaflet:

Download PDF Leaflet

Genetic Testing: Market Research Report
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is further analyzed by the following Segments: Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.

Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 88 companies including many key and niche players such as -
  • 23andMe, Inc.
  • Abbott Laboratories
  • AutoGenomics, Inc.
  • Biocartis NV
  • BioRad Laboratories
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Prenatal Diagnosis and Newborn Genetic Testing
Pharmacogenetics/Pharmacogenomics
Predictive Diagnostics

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

A Curtain Raiser
Top Ten Genetic Disorders Worldwide
Genetic Testing: Heralding a New Era
Genetic Testing Paves the Way for Personalized Medicine

Table 1. Drug Ineffectiveness for Select Therapeutic Categories - Necessitating Personalized Medicine (includes corresponding Graph/Chart)

Genetic Testing – A Critical Part of the Rapidly Developing In-Vitro Diagnostics (IVD) Market

Table 2. Global In Vitro Diagnostics (IVD) Market by Geographic Region (2016): Percentage Breakdown of Revenues for Asia-Pacific; Europe, Middle-East and Africa; North America; and Latin America (includes corresponding Graph/Chart)
Table 3. Global In-Vitro Diagnostics Market by Sector (2016): Percentage Breakdown of Revenues for Hospital & Commercial Laboratories, and Decentralized & Patient Self-Testing (includes corresponding Graph/Chart)
Table 4. Leading Players in the Global In Vitro Diagnostics Market (2016): Percentage Breakdown of Revenues for Abbott, Beckman Coulter, Roche, Siemens, Thermo Fisher and Others (includes corresponding Graph/Chart)

Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market

Table 5. Global Molecular Diagnostics Market (2016): Percentage Breakdown of Revenues for Blood Donor Screening, Genomics and Infectious Disease Testing (includes corresponding Graph/Chart)

An Overview of Current Technologies in Genetic Testing

Table 6. Global Genetic Testing Market by Technology (2016 & 2024): Percentage Breakdown of Revenue for Hybridization, Microarray, NGS and PCR (includes corresponding Graph/Chart)

Biomarker Discovery Leads to Advanced Genetic Testing
List of US-FDA Approved Biomarkers for Cancer
Ballooning Global Population Offers Increased Growth Opportunities

Table 7. Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (includes corresponding Graph/Chart)

Aging Population Drives the Genetic Testing Market

Table 8. Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
Table 9. Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)
Table 10. Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart)

Improving Healthcare Expenditure to Drive Demand

Table 11. Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)
Table 12. Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart)

Competitive Overview

2. SEGMENTAL REVIEW

Prenatal Testing Market to Rise
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Prenatal Testing – Changing the World of Pregnancy Care
Prenatal Testing – A Rudimentary Overview
List of Available Prenatal Screening and Diagnostic Tests by Indication
Conventional Invasive Pre-Natal Diagnostic Techniques – A Risky Affair
Other Negativities of Existing Invasive Techniques
Emergence of Non-Invasive Prenatal Diagnosis (NIPD)
US Leads in NIPD Market
Competition Intensifies in the NIPD Market
Commercially Available NIPD (Genetic) Tests for Aneuploidy in the US
NIPD Eliminates Risks and Uncertainty of Conventional Diagnostic Procedures
Opposition to NIPD Technique – A Significant Hurdle to Adoption
Benefits Outweigh Snags in NIPD Tests
Major Factors Influencing Penetration of NIPD Tests

Table 13. Price Comparison of Existing Tests and Screening Procedures for Down’s Syndrome

Diversity in NIPD Usage on the Cards
Expanded Newborn Screening
Technological Advancements Boost Prenatal Genetic Screening Market
CMA Stakes Claim as the First-Line Test in Fetal Abnormalities; Issues Hinder Growth
Strain on Resources Prevent Wide Adoption of Expanded Carrier Sequencing
Fetal Diagnostic WES – A Promising Advancement in Prenatal Screening
Predictive Diagnostics
Breast Cancer Gene Testing Market to Expand Strongly
Myriad Genetics – The Unquestioned Leader in Breast Cancer Testing
Routine Clinical Testing Vs. Predictive Genetic Testing
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
Discovery of Novel Biomarkers Crucial to Predictive Diagnostics
Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
Dearth of Genetic Counselors – A Major Hurdle for the Predictive Genetic Testing
Pharmacogenomics Development Augurs Growth of Genetic Testing Market

3. MARKET TRENDS

Direct-to-Consumer Genetic Testing – A Key Trend in the Genetic Testing Market
Direct-to-Consumer Genetic Testing is Here to Stay
Creating a Platform for New Companies
Business Models for DTC Genetic Testing Firms
Growing Prominence of DTC Genetic Testing: A Boon or a Curse?
Genetic Screening of Newborns to Rise
Pre-implantation Genetic Diagnosis (PGD) - A Major Driver for the Genetic Testing Market
Whole Genome Sequencing – Boon or Bane to Genetic Testing?
Utility of Genetic Testing for Warfarin Study
As Technologies Grow, Need for Better Interpretation of Tests Increases
Selling Collected Patient Genetic Information Becomes a New Business
Oncology – A Key Focus Area for Genetic Testing

Table 14. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
Table 15. New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
Table 16. Cancer Incidence in Developed Nations by Site: 2012 (includes corresponding Graph/Chart)
Table 17. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
Table 18. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
Table 19. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)

Liquid Biopsy to Change the Face of Cancer Diagnosis and Treatment
Genetic Testing May Aid CNS Disease Therapeutics
Neurodegenerative Diseases - Major Focus Area for Genetic Testing
Alzheimer’s Disease
Validity of Emerging Genetic Tests for Alzheimer’s
Newly Developed Test Predicts Age of Onset of Alzheimer’s
Huntington’s Disease

Table 20. Global Prevalence of Huntington’s Disease by Geographic Region (includes corresponding Graph/Chart)

Genetic Testing – An Indispensable Tool for Cystic Fibrosis

Table 21. Most Common Mutations and Worldwide Frequency (includes corresponding Graph/Chart)

Histocompatibility Testing
Next-Generation Sequencing – A Giant Leap in Genome Sequencing
Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance
Better Regulatory Safeguards Required for Global Genetic Testing Industry
Challenges Faced
Controversial Applications Marr Genetic Testing Market
Genetic Counseling: Gaining Momentum
Online Approach Gains Momentum
Recommendations of ACOG and ACGM Augments Demand for Cystic Fibrosis Testing
Ethical Issues & Need for Appropriate Regulating Policies
Issues Related to Genetic Tests for Obesity
Diagnosis and Treatment during Pregnancy - An Effective Way of Alleviating Syphilis Related Deaths and Stillbirths

4. MOLECULAR DIAGNOSTICS MARKET – AN INSIGHT

Global Molecular Diagnostics on a High Growth Curve
Automation Driving Global Market
Molecular Diagnostics: Marking the Convergence of Numerous Technologies
MDx Market for Infectious Diseases Zooming Ahead
Aging Population, Disease Incidence – Fundamental Drivers of Growth
Pharmaceutical Firms Carving Their Niche in Molecular Diagnostics Market
Towards Tailoring the Right Treatment for the Right Disease
Limited Reimbursements by Third Party Payers – A Stumbling Block
Disease-Specific Molecular Diagnostics to Deliver Improved Clinical Outcomes
Molecular Diagnostics and Intellectual Property
Business Opportunities in the Offing
Medical Training and Practice Challenges
Hurdles All the Way for Companies Eyeing Molecular Diagnostics
Product Marketing – Key to Commercial Success
Integration of Molecular Diagnostics into Therapeutics
Molecular Diagnostics – Moving from Centralization to Decentralization
Competitive Landscape of the Molecular Diagnostics Market

Table 22. Leading Players in the Global Molecular Diagnostics Market (2016): Percentage Breakdown of Value Sales for Abbott, Cepheid, Grifols, Hologic, Qiagen, Roche and Others (includes corresponding Graph/Chart)

New Entrants Eye Unmet Needs

5. PRODUCT OVERVIEW

Preface to Genetic Testing
Genetic Testing and its Applications
Gene Candidate and Genome Screen
‘DNA Chip’ to Chip into Genetic Field
Techniques Used to Identify Changes in Genes
Types of Genetic Testing
Prenatal Diagnosis
Cancer Testing
Carrier Identification
Newborn Screening
Predictive Testing
Pre-Symptomatic Testing
Cytogenetic Tests
Steps in Genetic Testing Process
Limitations
Risks and Other Limitations of Genetic Testing
Medical Institutions to Reap the Benefit of Genetic Testing
Pharmacogenetics/Pharmacogenomics
Review of Select Genetic Tests
Cystic Fibrosis
Breast and Ovarian Cancer (BRCA)
Alzheimer's disease
Colorectal Cancer
Haemochromatosis (HH)
Cowden Syndrome
Huntington's disease (HD)
Costs of Select Tests

Table 23. Costs of Select Genetic Tests

Genetic Testing Techniques
Signal Amplification Technologies
PCR – New Developments
Quantitative Real-Time PCR for Molecular Diagnostics
Signal Detection and Quantification
Quantitative Real-Time RT-PCR Analysis
Applications of Quantitative Real-Time PCR Analysis
Viral Detection and Viral-Load Monitoring
Sensitive Detection of Infectious Disease Agents
Predisposition Testing
Non-PCR Methods
Other Signal Amplification Technologies
DNA Probe Based Products
Direct Detection of Specific Nucleic Acid Sequences
Nucleic Acid Amplification and Detection
DNA Sequencing and Gene Detection
Arrays of Immobilized Probes (DNA Chips) in Gene Detection
RNA Diagnostics

6. PRODUCT LAUNCHES/INNOVATIONS

AutoGenomics Rolls Out INFINITI H. pylori Assay
23ANDME OBTAINS FDA APPROVAL FOR PERSONAL GENETIC TEST FOR SELECT DISEASES
Invitae Adds News Tests to Proactive Genetic Testing Repertoire
Thermo Fisher Scientific Launches CarrierScan Assay
MedGenome Unveils Claria Carrier Screening Test in India
Phosphorus Rolls Out Advances Tests for Inherited Conditions
Cancer Genetics Launches Genomic Panel for HBOC
Illumina, Bio‑Rad Launch Single-Cell Genomic Sequencing Solution
MyHeritage Introduces MyHeritage DNA Service
Thermo Fisher Scientific Unveils Clariom Pico Assays
IBM Watson Health, Quest Diagnostics Roll Out IBM Watson Genomics
Thermo Fisher Scientific Introduces PharmacoScan Solution
Good Start Genetics Launches EmbryVu PGS Test
Spark Therapeutics Introduces Testing for Inherited Retinal Diseases
AutoGenomics Launches INFINITI Buccal Sample Collection Kit
FutuTest Launches FERTIFY Genetic Test
Quest Diagnostics Introduces New Cancer Test Services
Good Start Genetics Launches Next-Generation Embryo Screening Solution
Invitae Introduces Pediatric Tests for Rare Disease and Pediatric Genetics
Contextual Genomics Introduces Cancer Genome Test
Transgenomic Introduces CMT NGS Panel
Ambry Genetics Rolls Out Suite of Genetic Testing Panels for Epilepsy
Good Start Genetics Introduces EmbryVu PGS Test
23ANDME SECURES FDA APPROVAL FOR NEW TRIMMED DOWN DNA-BASED HEALTH ANALYSIS
Roche Rolls Out Oncology Assay
AutoGenomics Launches INFINITI SMART
Transgenomic Rolls Out Transgenomic Leukodystrophy NGS Panel
Color Genomics Rolls Out New Test for Cancer-Associated Genes
PerkinElmer Launches Genetic Screening Processor Instruments in China
Mayo Clinic Launches Eight NGS Panels for Cardiac Disorders
Sequenom Laboratories and Recombine Launch HerediT UNIVERSAL
Multipicom NV Launches ADH MASTR v2 assay
23ANDME LAUNCHES DRUG DEVELOPMENT UNIT
Quest Diagnostics Launches Neurome Exome Sequencing Service
Roche Launches cobas 6800/8800 Systems
Agena Biosciences Launches MassARRAY 24-Well System
FDA Grants Marketing Approval to 23andMe’s DTC Bloom Syndrome Carrier Genetic Test
Transgenomic to Launch ICE COLD-PCR Technology
Rosetta Launches Sequencing-based Oncology Tests by Admera Health
MedGenome Labs Launches Panorama Prenatal Test
Ambry Genetics Launches CVD Genetic Testing Panels
Exceltox Launches Pharmacogenomic Testing
PerkinElmer Launches SCID Screening Test in North America
Quest Diagnostics Introduces BRCAvantage Plus
Genetic Technologies Launches BREVAGenplus Test
Sophia Genetics Receives CE-IVD Certification for Genetic Testing
Response Genetics Launches Immuno-Oncology Assay
DeNA Life Science Launches Mycode Genetic Testing Service
Pathway Genomics Launches BRCATrue Test
Courtagen Launches Genetic Sequencing Tests for Neurodevelopmental Disorders
Myriad Genetics Launches EndoPredict Breast Cancer Test
Assurex Health Expands GeneSight Pharmacogenomic Testing Platform
Illumina to Launch VeriSeq Embryo Screening Tool
GENEWIZ Launches PGxOne Pharmacogenomic Test
Ambry Genetics Launches ExomeNext and ExomeNext-Rapid Genetic Tests
Pathway Genomics Launches Genetic Test to Detect Risk of Colorectal Cancer
Mount Sinai Laboratory Develops Accurate Genetic Test for SMA

7. RECENT INDUSTRY ACTIVITY

Agilent Inks Deal to Take Over Multiplicom
DNA Diagnostics Center Acquires IDENTIGENE
Genetic Analysis and Bio-Rad Ink Deal for Transferring Commercialization Rights to GA-map
Thermo Fisher Files for PMA Approval of its Oncomine Universal Dx Test
LabCorp Takes Over Sequenom
WuXi AppTec and AutoGenomics Team Up to Launch Advanced Molecular Diagnostic Technology In China
Danaher to Take Over Cepheid
Quest Diagnostics to Offer Genetic Testing Services for Ancestry
Transgenomic and LabCorp Sign Commercial License Agreement for TBIO’s DNA Susceptibility Testing IP
Next Biosciences Merges with Genesis Genetics
PerkinElmer Expands Services in India
PerkinElmer Takes Over Vanadis Diagnostics
AutoGenomics and McKesson to Jointly Distribute INFINITI Molecular Diagnostic Systems and Related Products
Transgenomic Divests GAP Business
Thermo Fisher Teams Up with Novartis and Pfizer for Developing NGS Oncology Test
NeoGenomics Acquires Clarient
MedGenome to Build Data Specific to India for Testing Kits
Roche to Take Over Kapa Biosystems
Natera Selects DNAnexus Cloud Genomics Platform for its Genetic Tests
ESPERITE Acquires InKaryo
Transgenomic Signs Agreement with Exiqon A/S
Quest Diagnostics and Myriad Genetics End BRCA Gene Patent Litigation
Roche to Acquire Majority Share of Foundation Medicine
Roche Acquires Ariosa Diagnostics
GSK Collaborates with GE on Oncology Genetic Testing
Cancer Genetics to Acquire Gentris Corporation
Natera Partners with Mount Sinai Genetic Testing Laboratory
Transgenomic to Sell SURVEYOR Nuclease Technology to Integrated DNA Technologies
Transgenomic Collaborates with Raptor Pharmaceuticals for Genetic Testing Services
AutoGenomic Signs Agreement with Genomas
Cancer Genetics Acquires BioServe Biotechnologies
PerkinElmer to Close Its Signature Genomics Testing Business
LifeLabs Medical Laboratory Services Buys out Centogene’s Canadian Business
CytoScan Dx Assay by Affymetrix Receives FDA Approval

8. FOCUS ON SELECT PLAYERS

23ANDME, INC. (USA)
Abbott Laboratories (USA)
AutoGenomics, Inc. (USA)
Biocartis NV (Belgium)
BioRad Laboratories (USA)
Cepheid Inc. (USA)
ELITech Group S. P. A. (France)
Illumina, Inc. (USA)
Laboratory Corporation of America Holdings (USA)
Sequenom, Inc. (USA)
Luminex Corporation (USA)
Natera, Inc. (USA)
PerkinElmer, Inc. (USA)
QIAGEN N. V. (The Netherlands)
Quest Diagnostics, Inc. (USA)
Roche Diagnostics Corp. (Switzerland)
Roche Molecular Diagnostics, Inc. (USA)
Thermo Fisher Scientific (USA)
Transgenomic, Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE

Table 24. World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 25. World Historic Review for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26. World 14-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
The US: Leading Market for Genetic Testing Globally
Demographic Changes Offer Growth Opportunities

Table 27. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Burgeoning Potential for Genetic Testing
Use of Genomic Data in Clinical Settings to Gather Pace
Predictive Screening: Another Growth Area
An important Market for Personalized Medicine
Epidemic Proportion of Cancer in the US – Driver for Cancer Genetic Testing

Table 28. New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)
Table 29. Cancer Related Deaths by Gender in the US (2017E) (includes corresponding Graph/Chart)

Newborn Testing Gains Ground
Success Stories
Skepticism Limits Widespread Adoption of Genetic Testing
Favorable Reimbursement Policies
Favorable Insurance Coverage for Cystic Fibrosis Genetic Testing
Popularity of Screening and ACOG Guidelines Sink Invasive Prenatal Diagnosis Numbers
Tough Market Prospects for Sex Determination Tests
Coverage of NIPT in Average Risk Pregnancies Expands Target Market
Wastage from Unnecessary Genetic Testing – A Growing Concern
IP Landscape of NIPD Tests
US Patents of cff DNA-based NIPD Tests
Direct-to-Consumer Testing - A Growing Market
DTC Genetic Tests Provide POCT for Patients in Hospice Care
Competitive Overview
Myriad Eyes Diversification and Expansion for Growth
Natera Holds Fort in the NIPT Market

Table 30. Leading Players in the US Non-Invasive Prenatal Testing Market (2016): Percentage Breakdown of Revenue for Illumina, LabCorp/Sequenom, Natera, Roche and Others (includes corresponding Graph/Chart)

Invitae Banks on Low Cost Solutions for Expanding Revenues
Regulatory Environment
Genetic Information Nondiscrimination Act Boosts Genetic Testing
Stricter Regulations for DTC Genetic Testing
H. R. 1313 Bill Rakes New Controversy
FDA Attempts to Put a Leash around Unapproved DTC Genetic Tests
Negotiated Prices Bring Comfort to Several Diagnostic Companies
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 31. The US Recent Past, Current & Future Analysis for Genetic Testing by Segment - Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 32. The US Historic Review for Genetic Testing by Segment - Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 33. The US 14-Year Perspective for Genetic Testing by Segment - Percentage Breakdown of Revenues for Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current & Future Analysis
Regulatory Scenario
Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand

Table 34. New Cancer Cases in Canada (2016): Percentage Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)
Table 35. New Cancer Cases in Canada by Province (2016) (includes corresponding Graph/Chart)
Table 36. Cancer Incidence in Canada by Age Group and Gender: Age Standardized Incidence Rate per 100,000 People (2015) (includes corresponding Graph/Chart)

Product Launches
Strategic Corporate Development
B. Market Analytics

Table 37. Canadian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 38. Canadian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current & Future Analysis
Demographics Drive Market Growth

Table 39. Japanese Population by Age Group (2017) (includes corresponding Graph/Chart)

DTC Genetic Testing Regulatory Scenario
Product Launch
B. Market Analytics

Table 40. Japanese Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 41. Japanese Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Market Overview
An Insight into Molecular Diagnostics Markets in Europe
Cancer Trends

Table 42. Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Aging Population to Drive Demand for Genetic Testing

Table 43. Population Breakup by Age Group for Select EU-28 Countries: 2015 (as a Percentage of Total Population) (includes corresponding Graph/Chart)

European Personalized Medicine Market to Exhibit Robust Growth
Legislations/Regulatory Policies in Select European Countries
Legislations Governing Genetic Testing in Select European Countries
B. Market Analytics

Table 44. European Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45. European Historic Review for Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 46. European 14-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Current & Future Analysis
Regulatory Environment in France
Elitech Group S. P. A. - A Key Player
B. Market Analytics

Table 47. French Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 48. French Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current & Future Analysis
Parliamentary Regulations
B. Market Analytics

Table 49. German Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 50. German Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4C. ITALY

Market Analysis

Table 51. Italian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 52. Italian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current & Future Analysis
Increased Support for Personalized Medicine to Drive Genetic Testing
SMIP for Pharmacogenomic Testing
Increasing Need for Less Risky Prenatal Diagnostic Methods in the UK
Regulatory Scenario
Non-consensual Analysis of DNA Made Illegal
Principles for DTC Genetic Testing Laid out by HGC
B. Market Analytics

Table 53. The UK Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 54. The UK Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4E. REST OF EUROPE

A. Market Analysis
Current & Future Analysis
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 55. Rest of Europe Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 56. Rest of Europe Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current & Future Analysis
Healthcare Spending in Asia-Pacific: On the Rise
Select Regional Markets
China
China’s FDA Curbs Prenatal Testing
Genetic Testing to Reveal Real Talents in Children – A New Popular Application
India
Diagnostics Market in India
Genomic Medicine – Nascent yet Promising
Genetic Testing in India to Rise
Australia and New Zealand
Approval of Experiments on Human Embryos in New Zealand
Product Launches
Strategic Corporate Developments
B. Market Analytics

Table 57. Asia-Pacific Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 58. Asia-Pacific Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. REST OF WORLD

A. Market Analysis
Current & Future Analysis
Product/Service Launch
Strategic Corporate Development
B. Market Analytics

Table 59. Rest of World Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 60. Rest of World Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 88 (including Divisions/Subsidiaries - 97)
The United States (60)
Canada (5)
Japan (1)
Europe (23)
  France (2)
  Germany (3)
  The United Kingdom (2)
  Spain (1)
  Rest of Europe (15)
Asia-Pacific (Excluding Japan) (5)
Middle East (2)
Africa (1)
Skip to top


Global Genetic Testing Market Analysis US$ 1,200.00 Jan, 2012 · 65 pages

Ask Your Question

Genetic Testing: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: